Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure
Data(s) |
10/04/2009
|
---|---|
Identificador | |
Idioma(s) |
eng |
Publicador |
American Society of Clinical Oncology |
Relação |
http://dro.deakin.edu.au/eserv/DU:30060072/reynolds-consolidationtherapy-2009.pdf http://doi.org/10.1200/JCO.2008.18.8573 |
Palavras-Chave | #thalidomide consolidation #autologous stem cell transplantation (ASCT) #multiple myeloma (MM) #progression-free survival (PFS) #overall survival (OS) #prednisone therapy |
Tipo |
Journal Article |